Norethindrone
Back to searchMolecule Structure
Scientific Name
Norethindrone
Description of the Drug
Norethisterone is a synthetic second-generation progestin used for contraception, prevention of endometrial hyperplasia in hormone replacement therapy, and in the treatment of other hormone-mediated illnesses such as endometriosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00717
http://www.drugbank.ca/drugs/DB00717
Brand Name(s)
Aygestin, Camila, Errin, Heather, Incassia, Jencycla, Menzol, Micronor, Micronor hrt, Norethidrone, Norethindrone, Noriday, Norlutin, Nor-qd, Primolut n, Utovlan
Company Owner(s)
Glenmark Generics Limited, Watson Laboratories Inc, Naari Pte Ltd, Amneal Pharmaceuticals Of New York Llc, Allergan Sales Llc, Actavis Laboratories Ut Inc, Vintage Pharmaceuticals Llc, Lpi Holdings Inc, Warner Chilcott Co Llc, Warner Chilcott Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Progesterone receptor | SINGLE PROTEIN | AGONIST | CHEMBL208 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL23390 | ||
| PharmGKB | PA450651 | ||
| Human Metabolome Database | HMDB0014855 | ||
| DrugBank | DB00717 | ||
| PubChem: Thomson Pharma | 14873691 | 14873694 | |
| PubChem | 6230 | ||
| Mcule | MCULE-9156628994 | ||
| LINCS | LSM-4061 | ||
| Nikkaji | J1.416H | ||
| PDBe | NDR | ||
| BindingDB | 50148732 | ||
| EPA CompTox Dashboard | DTXSID9023380 | ||
| LipidMaps | LMST02030097 | ||
| DrugCentral | 1962 | ||
| ChemicalBook | CB0455127 | ||
| Guide to Pharmacology | 2880 | ||
| rxnorm | NORETHINDRONE | COMBIPATCH | FEMHRT |
| KEGG Ligand | C05028 | ||
| ChEBI | 7627 | ||
| ZINC | ZINC000085205451 |
